Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806
    BD:
    North China:Mr. Xiong 15339988450
    East and South China:Ms. Gu 15378638068
    East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key models for drug development in hyperlipidemia

Hyperlipidemia, also known as hyperlipidemia or dyslipidemia, usually refers to elevated plasma triglycerides and/or total cholesterol, elevated LDL cholesterol, and decreased HDL cholesterol. Hyperlipidemia carries the risk of complicating diseases such as coronary heart disease and cerebrovascular disease.
   We have established a stable model of hyperlipidemia, which is suitable for preclinical research and new drug evaluation of drugs for hyperlipidemia.
   If you have project needs and experience more of our professional services, please contact us.

Our services

Model classification

Model Name

Animal species

Hyperlipidemia

hyperlipidemia induced by high-fat feed alone

Rat

Hyperlipidemia model induced by high fat and high cholesterol feeds

Mice,golden gophers,rabbit,dogs,

 non-human primates

Case sharing


HFD-CHOL induced hamster hyperlipidemia model





Next:Liver fibrosis/cirrhosis